HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Gene expression profiling of multiple myeloma reveals molecular portraits in relation to the pathogenesis of the disease.

Abstract
Although multiple myeloma (MM) is a unique entity, a marked heterogeneity is actually observed among the patients, which has been first related to immunoglobulin (Ig) types and light chain subtypes and more recently to chromosomal abnormalities. To further investigate this genetic heterogeneity, we analyzed gene expression profiles of 92 primary tumors according to their Ig types and light chain subtypes with DNA microarrays. Several clusters of genes involved in various biologic functions such as immune response, cell cycle control, signaling, apoptosis, cell adhesion, and structure significantly discriminated IgA- from IgG-MM. Genes associated with inhibition of differentiation and apoptosis induction were up-regulated while genes associated with immune response, cell cycle control, and apoptosis were down-regulated in IgA-MM. According to the expression of the 61 most discriminating genes, BJ-MM represented a separate subgroup that did not express either the genes characteristic of IgG-MM or those of IgA-MM at a high level. This suggests that transcriptional programs associated to the switch could be maintained up to plasma cell differentiation. Several genes whose products are known to stimulate bone remodeling discriminate between kappa- and lambda-MM. One of these genes, Mip-1alpha, was overexpressed in the kappa subgroup. In addition, we established a strong association (P =.0001) between kappa subgroup expressing high levels of Mip-1alpha and active myeloma bone disease. This study shows that DNA microarrays enable us to perform a molecular dissection of the bioclinical diversity of MM and provide new molecular tools to investigate the pathogenesis of malignant plasma cells.
AuthorsFlorence Magrangeas, Valéry Nasser, Hervé Avet-Loiseau, Béatrice Loriod, Olivier Decaux, Samuel Granjeaud, François Bertucci, Daniel Birnbaum, Catherine Nguyen, Jean-Luc Harousseau, Régis Bataille, Rémi Houlgatte, Stéphane Minvielle
JournalBlood (Blood) Vol. 101 Issue 12 Pg. 4998-5006 (Jun 15 2003) ISSN: 0006-4971 [Print] United States
PMID12623842 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Chemokine CCL3
  • Chemokine CCL4
  • Immunoglobulin A
  • Immunoglobulin G
  • Immunoglobulin Heavy Chains
  • Immunoglobulin kappa-Chains
  • Immunoglobulin lambda-Chains
  • Macrophage Inflammatory Proteins
Topics
  • Adult
  • Aged
  • Apoptosis (genetics)
  • Cell Adhesion (genetics)
  • Chemokine CCL3
  • Chemokine CCL4
  • Gene Expression Profiling
  • Gene Rearrangement
  • Genes, MHC Class II
  • Genes, cdc
  • Humans
  • Immunoglobulin A (genetics)
  • Immunoglobulin G (genetics)
  • Immunoglobulin Heavy Chains (genetics)
  • Immunoglobulin kappa-Chains (genetics)
  • Immunoglobulin lambda-Chains (genetics)
  • Macrophage Inflammatory Proteins (genetics)
  • Middle Aged
  • Multiple Myeloma (genetics, immunology)
  • Oligonucleotide Array Sequence Analysis
  • Plasma Cells (immunology)
  • Reverse Transcriptase Polymerase Chain Reaction
  • Signal Transduction (genetics)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: